Main Menu

Clinical PhD Fellowships

Applications for a Cancer Research UK Clinical Academic Training Programme Fellowship are now open

Our clinical PhD fellowships have two funding streams both provided to develop and support future leaders in clinical cancer research;

The Wellcome Trust Clinical PhD programme is based at the Institute of Cancer Research and The Royal Marsden. You will receive expert supervision from the ICR’s top-class faculty and participate in the highly successful translational research culture of the ICR and The Royal Marsden NHS Foundation Trust.

The 'CRUK Clinical Academic Training Programme – ICR-Imperial' is a programme which will provide clinical academics with the expertise to discover, develop and deliver the next generation of treatments, technologies and methodologies into clinical care.

Both fellowship awards include tuition fees, research expenses, and a clinical salary.

Applicants from a range of clinical specialities are invited to apply, including oncology, paediatrics, radiology, surgery, anaesthesia and haematology.

Clinicians on this prestigious training programme will also benefit from: 

  • Mentoring from a senior clinical academic to support the transitions between clinical training and research
  •  A full programme of training tailored to the needs of the individual, including statistics, research methods, bioinformatics, laboratory skills, research integrity, academic writing and flexibly-delivered online training including Research Clinician and Perspectives in Oncology.
  • Access to our bespoke Clinical Academic Career Development programme, run through the ICR/RMH Biomedical Research Centre.
  • The ICR/RMH flagship Pathway to Independence - Clinical Academics in Cancer Research residential programme, providing intensive coaching to prepare you for academic independence and applications for clinician scientist awards.
  • Bridge funding for six months protected research time after the PhD to provide time to finish writing papers and prepare for further research funding applications.

Current fellowships

We currently have five projects open for one (1) 'Cancer Research UK Clinical Academic Training Programme – ICR-Imperial' fellowship which will start in Autumn 2020 (specific date to be arranged around contract dates of the awarded candidate).

The deadline for candidates to contact supervisors is Monday 29 June 2020.

Full applications are only open to individuals selected to proceed after this initial contact.

The deadline for full applications / joint proposals is Monday 27 July 2020.

Shortlisted applicants will be informed on the week commencing 10th August and asked to attend a panel interview in late August 2020 (dates to be confirmed).

For more details on eligibility criteria and what is required for these deadlines see the links below the project list.

Project List

Project - Targeting BCL2 family proteins in deubiquitinating enzyme 1 (DUB1; pseudonym) loss lethal prostate cancer

View project proposal


Project - Study of enhancer and transcription factor dynamics underlying children’s aggressive solid cancer evolutionary processes

View project proposal


Project - Optimising prostate radiotherapy – improving cure rates and reducing toxicity

View project proposal


Project - Deciphering cancer evolution through representative sequencing

View project proposal


Project - MRI directed diagnosis and radiotherapy response assessment for bladder cancer

View project proposal

Previously advertised fellowships

In this year's round we had thirteen projects open to applications, for up to five clinical training fellowships.

  • The deadline for candidates to contact supervisors has now passed and was Monday 21 October 2019.
  • Full applications are only open to individuals selected after this initial contact. 
  • The deadline for full applications / joint proposals is Monday 16 December 2019
  • Shortlisted applicants with be asked to attend a panel interview on Friday 7 February 2020
  • For more details on deadlines see 'how to apply' below

 Projects previously advertised:

(1)  B7-H3 (CD276) in prostate cancer biology and as a therapeutic target

(2) Bacteriophage Gene Therapy To Enhance Immunotherapy For Brain Tumours.

(3) BrainSpeech: Automated speech assessment as a biomarker in patients with brain tumours - A Phase II feasibility study

(4) Characterising and targeting sub-clonal diversity for improved patient stratification in therapy resistant (metastatic) lobular breast cancer

(5) Deciphering cancer evolution through representative sequencing

(6) Developing biomarkers for improving neoadjuvant chemotherapy in high-risk soft tissue sarcoma

(7) Efficient assessment of toxicity related outcomes in radiotherapy clinical trials

(8) Impact and Exploitation of Hypoxia on Therapeutic Strategies for Rhabdomyosarcoma.

(9) Radiomics and Machine Learning Stratification of Indeterminate Lung Nodules for Early Diagnosis of Lung Cancer.

(10) Sub-clonal RNASH2B/RB1 loss and phenotypic luminal-to-basal evolution and novel therapeutic vulnerabilities in treatment-resistant prostate cancer.

(11) Translational brain tumour research.

(12) Ultrasound tomography (UST) and elastography of the breast: quantitative biomarkers of stromal properties

(13) Unravelling mechanisms of acquired immunomodulatory drug resistance in myeloma

PhD studentships

Applications for PhD studentships are now open. We’re searching for the brightest minds in cancer research. The next deadline for applications is 27 September.

ICR values

Our values – developed together as an organisation – make it clear how each and every one of us work to meet our mission – to make the discoveries that defeat cancer.

Cancer Research UK logowellcome-logo-(black) 200x200px